Markets are Closed
Company Logo
CRY
CryoLife Inc.

Open

Previous Open

High

24.60

Previous High

Low

23.97

Previous Low

Close

24.18

Previous Close

Volume

132,970

Previous Volume

Company Profile

Description

Cryolife Inc is engaged in medical device manufacturing and distribution and in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It has two segments: Medical Devices and Preservation Services.

Exchange

New York Stock Exchange

List Date

July 16, 1997

CEO

James Patrick Mackin

Employees

1,000

Financials

Revenue

276.22M

Earnings

16.53M
289M
218M
147M
76M
5M
2015
2016
2017
2018

Splits

December 28, 20000.67%

Dividends

December 18, 2015$0.03
September 18, 2015$0.03
June 19, 2015$0.03
March 20, 2015$0.03
December 19, 2014$0.03
September 19, 2014$0.03
June 20, 2014$0.03
March 21, 2014$0.03
December 20, 2013$0.03
September 20, 2013$0.03
June 21, 2013$0.03

Related News

News post image: CryoLife Receives CE Mark for E-vita Open NEO™ Hybrid Stent Graft
CryoLife Receives CE Mark for E-vita Open NEO™ Hybrid Stent Graft
Mar 04, 2020 @ 21:05
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease....
finance yahoo
News post image: CryoLife Wins CE Mark, Boosts Mechanical Valve Foothold in EU
CryoLife Wins CE Mark, Boosts Mechanical Valve Foothold in EU
Mar 02, 2020 @ 13:59
CryoLife's (CRY) On-X AAP completes the company's On-Xs heart valve portfolio....
finance yahoo
News post image: Edited Transcript of CRY earnings conference call or presentation 13-Feb-20 9:30pm GMT
Edited Transcript of CRY earnings conference call or presentation 13-Feb-20 9:30pm GMT
Feb 20, 2020 @ 06:18
Q4 2019 CryoLife Inc Earnings Call...
finance yahoo
News post image: CryoLife (CRY) Tops Q4 Earnings Estimates
CryoLife (CRY) Tops Q4 Earnings Estimates
Feb 13, 2020 @ 23:05
CryoLife (CRY) delivered earnings and revenue surprises of 42.86% and -4.46%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?...
finance yahoo
News post image: CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results
CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results
Feb 13, 2020 @ 21:05
Fourth Quarter and Recent Business Highlights:...
finance yahoo
News post image: CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Feb 06, 2020 @ 17:31
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
finance yahoo
News post image: CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results
CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results
Jan 30, 2020 @ 13:34
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on Thursday, February 13, 2020 after the market closes. On that day, the Company will hold a teleconference call...
finance yahoo
News post image: Should You Worry About CryoLife, Inc.'s (NYSE:CRY) CEO Salary Level?
Should You Worry About CryoLife, Inc.'s (NYSE:CRY) CEO Salary Level?
Jan 21, 2020 @ 11:06
In 2014 Pat MacKin was appointed CEO of CryoLife, Inc. (NYSE:CRY). This analysis aims first to contrast CEO......
finance yahoo
News post image: CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial
CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial
Dec 23, 2019 @ 13:30
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) pursuant to an Investigational New Drug (IND) application to begin the PROACT Xa clinical trial, a...
finance yahoo
News post image: If You Had Bought CryoLife (NYSE:CRY) Shares Five Years Ago You'd Have Made 151%
If You Had Bought CryoLife (NYSE:CRY) Shares Five Years Ago You'd Have Made 151%
Dec 16, 2019 @ 11:08
CryoLife, Inc. (NYSE:CRY) shareholders might be concerned after seeing the share price drop 14% in the last quarter......
finance yahoo